Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.
Article Details
- CitationCopy to clipboard
Jochemsen R, Wesselman JG, van Boxtel CJ, Hermans J, Breimer DD
Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.
Br J Clin Pharmacol. 1983;16 Suppl 2:291S-297S.
- PubMed ID
- 6140948 [ View in PubMed]
- Abstract
Pharmacokinetics of oral brotizolam (0.50 mg) and triazolam (0.50 mg) were studied in healthy young volunteers. The plasma concentration profile of brotizolam can be described as a one compartmental open model with first-order absorption. The absorption of triazolam was less regular and in half of the subjects was not consistent with first-order kinetics. Inter-individual variability in absorption rate (peak times) was larger for brotizolam. Mean peak times were 1.1 +/- 1.0 h for brotizolam and 1.2 +/- 0.5 h for triazolam. Mean peak concentrations were 7.3 +/- 3.1 ng/ml and 5.0 +/- 3.9 ng/ml respectively. The elimination half-life of brotizolam was twice that of triazolam with mean values of 5.0 +/- 1.1 h and 2.6 +/- 0.7 h respectively. There was no correlation between the half-lives of the two drugs. Protein unbound fraction was similar for triazolam and brotizolam with mean values of 9.9 +/- 1.5% and 8.4 +/- 0.7% respectively.
DrugBank Data that Cites this Article
- Drugs